The Aurum Institute Npc

This study looks at how safe and tolerable two different TB prevention treatments are for pregnant women with HIV. About 252 pregnant women will take either a daily pill for one month or a weekly pill for three months. Researchers will also check how these treatments interact wit…

This study tests whether a 1-month daily TB prevention pill works as well as a 3-month weekly option in two groups: people living with HIV and HIV-negative household contacts of TB patients. About 1,000 participants in South Africa and India will be randomly assigned to one of th…

This study looks at how safe and effective a short, once-weekly treatment for latent tuberculosis (TB) is in children and teens with HIV who are taking the antiretroviral drug dolutegravir. The goal is to see if the TB drugs interact with the HIV medication and to check for side …